# An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis

> **NCT02655679** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vitae Pharmaceuticals, Inc.** · enrollment: 104 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** VTP-38543
- **OTHER:** Vehicle with Transcutol®P
- **OTHER:** Vehicle without Transcutol®P

## Key facts

- **NCT ID:** NCT02655679
- **Lead sponsor:** Vitae Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-15
- **Primary completion:** 2016-09-09
- **Final completion:** 2016-09-09
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655679, "An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02655679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*